Drug resistance to standard treatments is common in metastatic cancer: some reasons for this include tumor heterogeneity where cancer Read More
Halda Therapeutics raises $126M to overcome drug resistance in cancer
Avenda Health is a company that creates personalized prostate cancer treatment. Its cloud-based platform, iQuest, leverages a patient’s Read More
About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, and it’s the second leading Read More